diff --git a/domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md b/domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md index 8b800acc..a358105f 100644 --- a/domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md +++ b/domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md @@ -31,44 +31,44 @@ This has structural implications for how healthcare should be organized. Since [ ### Additional Evidence (confirm) -*Source: [[2024-09-19-commonwealth-fund-mirror-mirror-2024]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5* +*Source: 2024-09-19-commonwealth-fund-mirror-mirror-2024 | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5* The Commonwealth Fund's 2024 Mirror Mirror international comparison provides the strongest real-world proof of this claim. The US ranks **second in care process quality** (clinical excellence when care is accessed) but **last in health outcomes** (life expectancy, avoidable deaths) among 10 peer nations. This paradox proves that clinical quality alone cannot produce population health — the US has near-best clinical care AND worst outcomes, demonstrating that non-clinical factors (access, equity, social determinants) dominate outcome determination. The care process vs. outcomes decoupling across 70 measures and nearly 75% patient/physician-reported data is the international benchmark showing medical care's limited contribution to population health outcomes. ### Additional Evidence (extend) -*Source: [[2025-00-00-nhs-england-waiting-times-underfunding]] | Added: 2026-03-15* +*Source: 2025-00-00-nhs-england-waiting-times-underfunding | Added: 2026-03-15* The NHS paradox—ranking 3rd overall while having catastrophic specialty access—provides supporting evidence that medical care's contribution to health outcomes is limited. A system can have multi-year waits for specialty procedures yet still rank highly in overall health system performance because primary care, equity, and universal coverage (which address behavioral and social factors) matter more than specialty delivery speed for population health outcomes. ### Additional Evidence (confirm) -*Source: [[2025-12-01-who-glp1-global-guidelines-obesity]] | Added: 2026-03-16* +*Source: 2025-12-01-who-glp1-global-guidelines-obesity | Added: 2026-03-16* WHO's three-pillar framework for GLP-1 obesity treatment explicitly positions medication as one component within a comprehensive approach requiring healthy diets, physical activity, professional support, and population-level policies. WHO states obesity is a 'societal challenge requiring multisectoral action — not just individual medical treatment.' This institutional positioning from the global health authority confirms that pharmaceutical intervention alone cannot address health outcomes driven by behavioral and social factors. ### Additional Evidence (extend) -*Source: [[2025-04-07-tufts-health-affairs-medically-tailored-meals-50-states]] | Added: 2026-03-18* +*Source: 2025-04-07-tufts-health-affairs-medically-tailored-meals-50-states | Added: 2026-03-18* While social determinants predict health outcomes in observational studies, RCT evidence from food-as-medicine interventions shows that directly addressing social determinants (food insecurity) does not automatically improve clinical outcomes. The AHA 2025 systematic review of 14 US RCTs found Food Is Medicine programs improve diet quality and food security but "impact on clinical outcomes was inconsistent and often failed to reach statistical significance." This suggests the causal pathway from social determinants to health is more complex than simple resource provision. ### Additional Evidence (extend) -*Source: [[2025-01-01-produce-prescriptions-diabetes-care-critique]] | Added: 2026-03-18* +*Source: 2025-01-01-produce-prescriptions-diabetes-care-critique | Added: 2026-03-18* The Diabetes Care perspective provides a specific mechanism example: produce prescription programs may improve food security (a social determinant) without improving clinical outcomes (HbA1c, diabetes control) because the causal pathway from social disadvantage to disease is not reversible through single-factor interventions. This demonstrates the 10-20% medical care contribution in practice—addressing one SDOH factor (food access) doesn't overcome the compound effects of poverty, stress, and social disadvantage. ### Additional Evidence (confirm) -*Source: [[2026-03-19-vida-ai-biology-acceleration-healthspan-constraint]] | Added: 2026-03-19* +*Source: 2026-03-19-vida-ai-biology-acceleration-healthspan-constraint | Added: 2026-03-19* Amodei's complementary factors framework explicitly identifies 'human constraints' (behavior change, social systems, meaning-making) as a factor that bounds AI returns even in biological science. This provides theoretical grounding for why the 80-90% non-clinical determinants remain unaddressed by AI-accelerated biology—they fall into the 'human constraints' category that AI cannot optimize. --- ### Additional Evidence (confirm) -*Source: [[2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy]] | Added: 2026-03-24* +*Source: 2026-03-10-abrams-bramajo-pnas-birth-cohort-mortality-us-life-expectancy | Added: 2026-03-24* PNAS 2026 attributes US life expectancy stagnation to 'a complex convergence of rising chronic disease, shifting behavioral risks, and increases in certain cancers among younger adults' — explicitly identifying behavioral and social factors as the drivers of cohort-level mortality deterioration, not medical care quality.